Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Achaogen, U.S. Department of Health and Human Services infectious news

    Achaogen Inc. (NASDAQ:AKAO), South San Francisco, Calif. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious HHSs Biomedical Advanced Research and Development Authority (BARDA) exercised…

    Published on 6/27/2016
  • Chiasma endocrine/metabolic news

    Chiasma Inc. (NASDAQ:CHMA), Waltham, Mass. Business: Endocrine/Metabolic Chiasma will reduce headcount by about 33% after FDA issued a complete response letter in April to an NDA for Mycapssa octreotide (RG3806) as a …

    Published on 6/27/2016
  • Novartis biosimilars news

    Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars Novartis Sandoz Inc. unit said it plans to launch five biosimilars worldwide by 2020. The planned launches include GP2015, a biosimilar of …

    Published on 6/27/2016
  • Semma Therapeutics, Brigham and Womens Hospital, Dana-Farber Cancer Institute, Harvard, Joslin Diabetes Center endocrine/metabolic news

    Semma Therapeutics Inc., Cambridge, Mass. Brigham and Womens Hospital, Boston, Mass. Dana-Farber Cancer Institute, Boston, Mass. Harvard University, Cambridge, Mass. Joslin Diabetes Center, Boston, Mass. Business: …

    Published on 6/27/2016
  • Atox Bio, U.S. Department of Health and Human Services infectious news

    Atox Bio Inc., Ness Ziona, Israel U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious HHSs Biomedical Advanced Research and Development Authority (BARDA) exercised an option under a 2014 …

    Published on 6/20/2016
  • Medivir infectious, neurology, musculoskeletal news

    Medivir AB (SSE:MVIR B), Huddinge, Sweden Business: Infectious, Neurology, Musculoskeletal Medivirs board tasked management to consider dividing the company into two independent companies: an R&D company and a …

    Published on 6/20/2016
  • Gilead, Ionis Pharmaceuticals, Merck infectious news

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Ionis Pharmaceuticals Inc. (NASDAQ:IONS), Carlsbad, Calif. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Business: Infectious A federal judge reversed a …

    Published on 6/13/2016
  • Catalyst Pharmaceuticals autoimmune news

    Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX), Coral Gables, Fla. Business: Autoimmune Catalyst reduced headcount by about 30% to conserve cash to complete requirements for an NDA submission for Firdapse amifampridine …

    Published on 6/6/2016
  • Neuralstem neurology news

    Neuralstem Inc. (NASDAQ:CUR), Rockville, Md. Business: Neurology Neuralstem will reduce headcount across all divisions to focus on developing NSI-189 and pursuing partnerships for NSI-566. NSI-189, a small molecule …

    Published on 6/6/2016
  • Bavarian Nordic, U.S. Department of Health and Human Services infectious news

    Bavarian Nordic A/S (CSE:BAVA), Kvistgaard, Denmark U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious Bavarian Nordic said HHSs Biomedical Advanced Research and Development Authority (…

    Published on 5/30/2016
  • PDI Therapeutics Inc., GlaxoSmithKline cancer news

    PDI Therapeutics Inc., La Jolla, Calif. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Cancer Avalon Ventures launched cancer immunotherapy company PDI Therapeutics as part of an expanded build-to-buy …

    Published on 5/30/2016
  • Pelican, Cancer Prevention & Research Institute of Texas cancer news

    Pelican Therapeutics Inc., Austin, Texas Cancer Prevention & Research Institute of Texas (CPRIT), Austin, Texas Business: Cancer CPRIT awarded Pelican a $15.3 million New Company Product Development Award to develop …

    Published on 5/30/2016
  • Bavarian Nordic, U.S. Department of Health and Human Services infectious news

    Bavarian Nordic A/S (CSE:BAVA), Kvistgaard, Denmark U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious Bavarian Nordic said HHS's Biomedical Advanced Research and Development Authority (…

    Published on 4/28/2014
  • Boehringer Ingelheim biosimilars news

    Boehringer Ingelheim GmbH, Ingelheim, Germany Business: Biosimilars Boehringer Ingelheim disclosed that it is conducting Phase III trials evaluating biosimilars of autoimmune drug Humira adalimumab, cancer drug Avastin …

    Published on 4/28/2014
  • Celgene, Stryker, Sanofi other news

    Celgene Corp. (NASDAQ:CELG), Summit, N.J. Stryker Corp. (NASDAQ:SYK), Kalamazoo, Mich. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Other Judge Katharine Hayden for the U.S. District Court for the District …

    Published on 4/28/2014
  • Danco Laboratories LLC genitourinary news

    Danco Laboratories LLC, New York, N.Y. Business: Genitourinary Oklahoma Gov. Mary Fallin signed into law a bill that prohibits off-label use of Danco's Mifeprex mifepristone (RU-486), which is indicated for the medical …

    Published on 4/28/2014
  • Eli Lilly, J&J, Merck, Roche cancer, autoimmune news

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Cancer,…

    Published on 4/28/2014
  • Endo, Hisamitsu, Teikoku Seiyaku, TWi Pharmaceuticals neurology news

    Endo International plc (NASDAQ:ENDP; TSX:ENL), Dublin, Ireland Hisamitsu Pharmaceutical Co. Inc. (Tokyo:4530), Tosu, Japan Teikoku Seiyaku Co. Ltd., Higashikagawa, Japan TWi Pharmaceuticals Holding Inc. (GreTai:4180), …

    Published on 4/28/2014
  • Endofotonics, National University of Singapore diagnostic news

    Endofotonics Pte. Ltd., Singapore National University of Singapore, Singapore Business: Diagnostic The university spun off newco Endofotonics, which is developing its IMDX molecular diagnostic system for instant cancer …

    Published on 4/28/2014
  • Genetic Technologies, ImmunAid Ltd. other news

    Genetic Technologies Ltd. (ASX:GTG; NASDAQ:GENE), Fitzroy, Australia ImmunAid Ltd., Fitzroy, Australia Business: Other At an extraordinary general meeting, Genetic shareholders approved a deal in which founder Mervyn …

    Published on 4/28/2014
  • Teva autoimmune news

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Autoimmune The U.S. Supreme Court denied a motion from Teva to stay an appeals court ruling that will end exclusivity for the biotech's …

    Published on 4/28/2014
  • XenoPort autoimmune, neurology news

    XenoPort Inc. (NASDAQ:XNPT), Santa Clara, Calif. Business: Autoimmune, Neurology XenoPort investor Clinton Relational Opportunity Master Fund L.P. has nominated a slate of three directors to the biotech's board to …

    Published on 4/28/2014
  • Zogenix neurology news

    Zogenix Inc. (NASDAQ:ZGNX), San Diego, Calif. Business: Neurology Massachusetts Gov. Deval Patrick said doctors are now required to check a patient's controlled-substance history through a statewide prescription …

    Published on 4/28/2014
  • Applikon Biotechnology biomanufacturing news

    Applikon Biotechnology B.V., Delft, the Netherlands Business: Biomanufacturing Applikon launched a new production facility in Guangzhou, China. The company said the facility will provide a range of bioreactor systems, …

    Published on 3/24/2014
  • Arrowhead, Calando drug delivery, cancer news

    Arrowhead Research Corp. (NASDAQ:ARWR), Pasadena, Calif. Calando Pharmaceuticals Inc., Pasadena, Calif. Business: Drug delivery, Cancer Arrowhead said that subsidiary Calando ceased day-to-day operations after it …

    Published on 3/24/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993